Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nuvalent Inc Cl A (NQ: NUVL )

108.00 +4.75 (+4.60%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,779,589
Open 103.99
Bid (Size) 43.20 (2)
Ask (Size) 109.97 (1)
Prev. Close 103.25
Today's Range 102.72 - 108.98
52wk Range 41.16 - 113.51
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Nuvalent (NUVL) Shares Are Down 6% Today
Nuvalent shares are trading lower by 6.2% during Tuesday's session. The company priced a $500 million public offering of 5 million shares at $100 each. 
Via Benzinga
Nuvalent Stock Jumps On ESMO Data Presentation, Seeks To Raise $350M Via Equity
Nuvalent presented updated Phase 1 data from its ARROS-1 and ALKOVE-1 trials at the ESMO Congress 2024. Key data showed promising response rates in pretreated patients, with pivotal results expected in... 
Via Benzinga

Performance

YTD
+41.92%
+41.92%
1 Month
+30.66%
+30.66%
3 Month
+36.28%
+36.28%
6 Month
+39.10%
+39.10%
1 Year
+150.17%
+150.17%

More News

Read More
Nuvalent Flies On 'Multibillion-Dollar' Potential, While Iteos Crashes On Patient Deaths
Via Investor's Business Daily
Topics Death
Exposures Death
Crude Oil Surges Over 1%; Instil Bio Shares Plunge
Via Benzinga
Exposures Fossil Fuels
Alcoa, Lattice Semiconductor, Stratasys And Other Big Stocks Moving Higher On Monday
Via Benzinga
NUVL Stock Earnings: Nuvalent Misses EPS for Q2 2024
Via InvestorPlace
NUVL Stock Earnings: Nuvalent Misses EPS for Q1 2024
Via InvestorPlace
Recap: Nuvalent Q4 Earnings
Via Benzinga
Lucid, Grifols And Amer Sports Are Among Top 8 Mid Cap Stock Gainers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio?
Via Benzinga
3 Short-Squeeze Stocks Poised for a Jaw-Dropping Rally
Via InvestorPlace
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
Via Benzinga
Recap: Nuvalent Q3 Earnings
Via Benzinga
7 Biotech Stocks to Get In Now Before Investors Catch On
Via InvestorPlace
Where Nuvalent Stands With Analysts
Via Benzinga
Why Nuvalent Stock Was Soaring Wednesday
Via The Motley Fool
Why Nuvalent Stock Tanked on Tuesday
Via The Motley Fool
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
Via Benzinga
Why Nuvalent Stock Skyrocketed 35% This Week
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Challenging Road Ahead for Cancer Drugs, Nuvalent Seeks to Break the Mold
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
Via Benzinga
Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Canopy Growth, DocGo And Other Big Stocks Moving Lower On Monday
Via Benzinga
7 A-Rated Biotech Stocks for Your August Buy List
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.